Pharmacological Thromboprophylaxis Effectiveness in Low-Risk Patients Underwent Arthroscopic Anterior Cruciate Ligament Reconstruction: A Randomized Clinical Trial
Pharmacological Thromboprophylaxis Effectiveness in ACL Reconstruction
Abstract
Purpose: This study aims to evaluate the effectiveness and safety of Aspirin and LMWH in an arthroscopic anterior cruciate ligament (ACL) reconstruction of low-risk patients.
Material and Methods: We conduct a single-center, assessor-blind, simple randomized clinical trial from March 2019- May 2020. 18 to 45 years old patients with ACL rupture without concomitant injury, diagnosed by magnetic resonance imaging, enrolled in the study. Selected subjects were allocated between three parallel arms of the study, with 46 participants.
Three parallels are 8o mg aspirin bid for 14 days, LMWH subcutaneous injection for 14 days, and no treatment parallel. Effectiveness outcomes were estimated by the DVT rate and PE rate, and safety was checked out by bleeding or hemarthrosis. Orthopedists assessed knee effusion with stroke score and ask patients for any symptoms during weekly clinic visits. The radiologist performed ultrasonography of lower extremities, searching for a sign of DVT.
Results: Mean age of participants was 31.4 + 5.6, and 93 individuals (67%) were male and 23% were female. No DVT and PE were observed. Three cases in the LMWH and one case in aspirin groups had minor surgical site bleeding. One case of hemarthrosis with normal ultrasonography occurred in the LMWH group. Regarding safety and effectiveness, there was no statistically significant difference between the parallels.
Conclusion: Use of LMWH or Aspirin after simple arthroscopic ACL reconstruction in low-risk patients have no different effectiveness. Hence routine use of thromboprophylaxis in this setting is questionable, although adverse events are rare.
1. Moses B, Orchard J, Orchard J. Systematic review: annual incidence of ACL injury and surgery in various populations. Research in Sports Medicine. 2012;20(3-4):157-79.
2. Oro FB, Sikka RS, Wolters B, Graver R, Boyd JL, Nelson B, et al. Autograft versus allograft: an economic cost comparison of anterior cruciate ligament reconstruction. Arthroscopy: The Journal of Arthroscopic & Related Surgery. 2011;27(9):1219-25.
3. Salzler MJ, Lin A, Miller CD, Herold S, Irrgang JJ, Harner CD. Complications after arthroscopic knee surgery. The American journal of sports medicine. 2014;42(2):292-6.
4. Sajjadi MRM, Zandi R, Okhovatpour MA, Jalalpour P, Moshari MR. Comparing the Effectiveness of Intra-Articular Injection of Bupivacaine, Dexmedetomidine Vs. 0.9% Saline on Pain Control after Arthroscopic Anterior Cruciate Ligament Reconstruction. Journal of Orthopedic and Spine Trauma. 2018:23-5.
5. Flevas D, Megaloikonomos P, Dimopoulos L, Mitsiokapa E, Koulouvaris P, Mavrogenis A. Thromboembolism prophylaxis in orthopaedics: an update. EFORT Open Rev 3 (4): 136–148. 2018.
6. Sharif-Kashani B, Mohebi-Nejad A, Abooturabi S-M. Estimated prevalence of venous thromboembolism in Iran: Prophylaxis still an unmet challenge. Tanaffos. 2015;14(1):27.
7. Pisoudeh K, Mortazavi SJ, Kamrani RS, Seyyedhosseinzadeh SH, Abolghasemian M. Prophylaxis of venous thromboembolism in orthopedic trauma patients: A review. Journal of Orthopedic and Spine Trauma. 2017.
8. Erickson BJ, Saltzman BM, Campbell KA, Fillingham YA, Harris JD, Gupta AK, et al. Rates of deep venous thrombosis and pulmonary embolus after anterior cruciate ligament reconstruction: a systematic review. Sports Health. 2015;7(3):261-6.
9. Gali JC, Camargo DB. Thromboprophylaxis for total knee arthroplasty. Revista brasileira de ortopedia. 2019;54:1-5.
10. Jacobs JJ, Mont MA, Bozic KJ, Della Valle CJ, Goodman SB, Lewis CG. American Academy of Orthopaedic Surgeons clinical practice guideline on: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. The Journal of Bone and Joint Surgery American volume. 2012;94(8):746.
11. Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE, Schulman S, et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2):e278S-e325S.
12. Keller RA, Moutzouros V, Dines JS, Bush-Joseph CA, Limpisvasti O. Deep venous thrombosis prophylaxis in anterior cruciate ligament reconstructive surgery: what is the current state of practice? Sports health. 2018;10(2):156-9.
13. Mokhtari M, Salameh P, Kouchek M, Kashani B, Taher A, Waked M, et al. The AVAIL ME Extension: a multinational Middle Eastern survey of venous thromboembolism risk and prophylaxis. Journal of Thrombosis and Haemostasis. 2011;9(7):1340-9.
14. Sturgill LP, Snyder-Mackler L, Manal TJ, Axe MJ. Interrater reliability of a clinical scale to assess knee joint effusion. journal of orthopaedic & sports physical therapy. 2009;39(12):845-9.
15. Zhu J, Jiang H, Marshall B, Li J, Tang X. Low-Molecular-Weight heparin for the prevention of venous thromboembolism in patients undergoing knee arthroscopic surgery and anterior cruciate ligament reconstruction: a meta-analysis of randomized controlled trials. The American journal of sports medicine. 2019;47(8):1994-2002.
16. Huang H-F, Tian J-L, Yang X-T, Sun L, Hu R-Y, Yan Z-H, et al. Efficacy and safety of low-molecular-weight heparin after knee arthroscopy: a meta-analysis. PLoS One. 2018;13(6):e0197868.
17. Zheng G, Tang Q, Shang P, Pan X-Y, Liu H-X. No effectiveness of anticoagulants for thromboprophylaxis after non-major knee arthroscopy: a systemic review and meta-analysis of randomized controlled trials. Journal of thrombosis and thrombolysis. 2018;45(4):562-70.
18. David Kaye I, Patel DN, Strauss EJ, Alaia MJ, Garofolo G, Martinez A, et al. Prevention of Venous Thromboembolism after Arthroscopic: Knee Surgery in a Low-Risk Population with the Use of Aspirin A Randomized Trial. Bulletin of the Hospital for Joint Diseases. 2015;73(4).
19. Kassaï B, Boissel J-P, Cucherat M, Sonie S, Shah NR, Leizorovicz A. A systematic review of the accuracy of ultrasound in the diagnosis of deep venous thrombosis in asymptomatic patients. Thrombosis and haemostasis. 2004;91(04):655-66.
Files | ||
Issue | Vol 10 No 3 (2024) | |
Section | Research Articles | |
DOI | https://doi.org/10.18502/jost.v10i3.16779 | |
Keywords | ||
Venous thromboembolism; Arthroplasty; Randomized Controlled Trial; Heparin Low-Molecular-Weight; Aspirin |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |